Micafungin Sodium for Injection Market

Micafungin (trade name Mycamine) is an echinocandin antifungal drug used to treat and prevent invasive fungal infections including candidemia, abscesses and esophageal candidiasis. It inhibits the production of beta-1,3-glucan, an essential component of fungal cell walls. Micafungin is administered intravenously. It received final approval from the U.S. Food and Drug Administration on March 16, 2005, and gained approval in the European Union on April 25, 2008.
Micafungin Sodium for Injection Market contains market size and forecasts of Micafungin Sodium for Injection in global, including the following market information:

• Global Micafungin Sodium for Injection Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Micafungin Sodium for Injection Market Sales, 2017-2022, 2023-2028, (K Units)
• Global top five Micafungin Sodium for Injection companies in 2021 (%)

The global Micafungin Sodium for Injection market was valued at 350.6 million in 2021 and is projected to reach US$ 297.9 million by 2028, at a CAGR of -2.3% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
50 mg Single-use Vial Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Micafungin Sodium for Injection include Astellas. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Micafungin Sodium for Injection manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Micafungin Sodium for Injection Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Micafungin Sodium for Injection Market Segment Percentages, by Type, 2021 (%)

• 50 mg Single-use Vial
• 100 mg Single-use Vial

Global Micafungin Sodium for Injection Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Micafungin Sodium for Injection Market Segment Percentages, by Application, 2021 (%)

• Candidemia
• Respiratory Mycosis
• Gastrointestinal Mycosis

Global Micafungin Sodium for Injection Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Micafungin Sodium for Injection Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa
• Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Micafungin Sodium for Injection revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Micafungin Sodium for Injection revenues share in global market, 2021 (%)
• Key companies Micafungin Sodium for Injection sales in global market, 2017-2022 (Estimated), (K Units)
• Key companies Micafungin Sodium for Injection sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Astellas

To know more about market statistics, Download a FREE Sample copy